Quantum BioPharma Ltd.
QNTM
$18.09
$0.0350.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.02M | -20.88M | -14.20M | -10.24M | -7.47M |
| Total Depreciation and Amortization | 504.70K | 500.10K | 490.50K | 499.90K | 525.90K |
| Total Amortization of Deferred Charges | 1.49M | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.33M | 614.90K | -2.92M | -260.30K | -1.83M |
| Change in Net Operating Assets | 7.19M | 10.60M | 9.76M | 3.10M | 3.63M |
| Cash from Operations | -10.51M | -9.16M | -6.88M | -6.89M | -5.14M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 31.80K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.93M | -2.83M | -1.50M | -2.75M | 414.70K |
| Cash from Investing | -4.93M | -2.83M | -1.50M | -2.75M | 446.50K |
| Total Debt Issued | 5.78M | 3.84M | 1.01M | 0.00 | 302.80K |
| Total Debt Repaid | -876.80K | -72.30K | -63.70K | -59.20K | -109.40K |
| Issuance of Common Stock | 8.72M | 10.42M | 10.67M | 9.19M | 2.14M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.63M | 14.18M | 11.62M | 9.13M | 2.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.81M | 2.19M | 3.24M | -513.70K | -2.36M |